Rex Cancer Center is a clinical research site located in Raleigh, North Carolina, United States 27607.
Crixeo Health Trust Score: 83/100 (GOOD). This profile has not yet been claimed by the site owner.
Rex Cancer Center has participated in 25 clinical trials with 8 currently active.
Therapeutic areas: Chronic Myeloid Leukemia, Metastatic Cancer, Prostate Cancer.
Sponsors: Rex Cancer Center, Raleigh, NC, Alliance Foundation Trials, LLC., Radiation Therapy Oncology Group.
Trust Score: 83/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Rex Cancer Center has a Crixeo Trust Score of 83/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Rex Cancer Center has 25 clinical trials on record, with 8 currently active. Their work covers Chronic Myeloid Leukemia, Metastatic Cancer, Prostate Cancer.
Yes — Rex Cancer Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.